Press Releases

Amplifyer Bio Publishes Liquid Biopsy Preclinical Data on Showing up to 100-Fold Increase in ctDNA Recovery

Data shows priming agents improved sensitivity for disease detection and mutational profiling while preserving key cfDNA features.

Avenda Health Expands Private Practice Network with the Deployment of Unfold AI at Arizona Urology, Bringing AI Prostate Cancer Mapping to the Southwest

Leading Phoenix urology practice adopts advanced AI cancer mapping to personalize surgical planning, enhance patient visualization, and pave the way for outpatient treatments

RealTime Laboratories Launches 31-Marker Mycotoxin Extensive Panel, the Most Comprehensive Urinary Mycotoxin Test on the Market

The expanded panel pairs the industry’s largest-ever marker count with methodology upgrades designed to give practitioners and patients the most comprehensive view of mold exposure yet, supporting more informed clinical decisions.

Revecore Launches Legal Appeals Service to Pursue the Complex Denials Hospitals Struggle to Overturn

IQVIA MedTech Introduces Surgical Collaboration Platform to Help Scale Surgeon Education

IQVIA MedTech is highlighting its Surgical Collaboration Platform, designed to help MedTech organizations coordinate and scale surgeon-to-surgeon education. The platform brings surgeon requests, credentialing, faculty matching, scheduling, documentation, training completion and reporting into a connected workflow as increasingly sophisticated medical technologies create greater demands on clinician education.

BOC Sciences Announces October 2026 Webinars on Vaccine Development and DNA-Encoded Chemistry

Neuland accelerates peptide manufacturing expansion to meet rising customer demand

Reckitt Plans $600 Million U.S. Expansion Across R&D and Manufacturing

Reckitt plans to invest up to $600 million across New Jersey and North Carolina to strengthen U.S. R&D, innovation and OTC manufacturing. The investment will create a new science and innovation center and expand its largest U.S. OTC facility to support Mucinex, Move Free and future healthcare product demand.

Complex-molecule specialist Shilpa CDMO launches at CPHI Milan

IQVIA Launches Data Device Link to Connect Diagnostic and Device Data With the Broader Patient Journey

IQVIA MedTech has launched Data Device Link (DDL), a new capability that connects patient-level data generated by medical devices and diagnostics with longitudinal healthcare data to provide a broader view of the patient journey. By linking device and diagnostic data with sources such as claims, prescriptions, laboratory data and electronic health records, DDL is designed to help manufacturers generate real-world evidence, evaluate outcomes and support regulatory and post-market research. The announcement also highlights real-world applications of this approach, including the use of data linkage to address missing demographic information for an FDA representativeness assessment and the development of a post-market registry supporting five years of patient outcomes monitoring.

Psychedelic Medicines Approach a Historic FDA Approval Milestone with Safety Under Scrutiny

The FDA's historic psychedelic hearing highlighted a critical question: how can psychedelic medicines become accessible without compromising patient safety? As developers move closer to potential approvals, regulators must balance clinical evidence, professional oversight, workforce training, geographic access and long-term safety.

Qinecsa selected as technology partner for Africa’s new continent-wide medicines safety platform

Qinecsa has been selected as technology partner for AfriVigilance, the African Medicines Agency’s new continent-wide medicines safety surveillance platform, with implementation already underway.

FDA Approves AstraZeneca’s Etcamah, Bringing ctDNA-Guided Treatment to Breast Cancer

AstraZeneca’s Etcamah has received FDA accelerated approval for ctDNA-guided treatment in HR-positive, HER2-negative breast cancer with ESR1 mutations. The decision could establish an earlier treatment-switch strategy based on molecular changes before cancer becomes visible on scans.

Sakura Finetek Europe launches Sakura Pathology Network

Sakura Finetek Europe today announced the launch of the Sakura Pathology Network (SPN), a new European network bringing together early-career pathologists from across Europe.

Biocon Secures 10-Year Supply Contract for Pertuzumab in Brazil

Biocon has secured a 10-year PDP allocation for pertuzumab in Brazil through a partnership with Bahiafarma and Bionovis, covering around 70% of the country’s public-sector demand. The agreement combines long-term supply with phased local production, supporting affordable cancer treatment access and strengthening Brazil’s domestic biopharmaceutical capabilities.

Yourgene Health Insight DPYD Assay Achieves IVDR Accreditation

Comprehensive pharmacogenetic testing solution aligned with latest clinical guidance to support informed chemotherapy treatment decisions

Sun Pharma Highlights U.S. Pricing and Access Commitments at White House Ceremony With Trump

Sun Pharma’s new US agreement highlights the changing landscape of pharmaceutical pricing, where affordability is becoming increasingly important for market access. The deal also shows how pricing, innovation and investment are becoming closely connected as global pharma companies adapt to changing US healthcare policies.

Integrion Automation Builds on Its Medical Device Capabilities to Support Validated, Traceable Production

Integrion Automation provides validated, traceable automation solutions for medical device manufacturers, helping improve quality, compliance, and flexibility in regulated production environments. Its GAMP 5-based approach, validation services, advanced inspection and assembly technologies, and lifecycle support help manufacturers reduce risk while maintaining audit-ready operations.

Inceptua Acquires SupplyRx to Enhance Pharmacy Services for Clinical Trials

Inceptua Group today announced the acquisition of SupplyRx to enhance pharmacy services for clinical trials.

New Dx World Summit to Unite the Global Diagnostics Ecosystem in Washington, D.C., August 23-25, 2027

Dx World Summit launches in Washington, D.C., August 23–25, 2027, bringing together 500+ diagnostics professionals across six conference tracks and the full diagnostic development continuum. Created by uniting Next Generation Dx Summit and TRI-CON and launched in partnership with Diagnostics World News, Dx World will be a new destination for diagnostic innovation, collaboration, and industry insight.